Skip to content

Lise Delagrange

Active Private limited companyfounded 2020active for 6 yearsH. Moeremanslaan 36, 1700 DilbeekKBO/BCE: BE 0755.943.368

Lifetime

6 annual accounts with figures on one time axis
peak of €21,696 in 2020
€8,491▲ 58.3%
lowest -€14,810 in 2023
€1,045▲ €3,162
peak of €43,130 in 2022
€24,849▲ 1.0%
€16,258▼ 15.1%
Board1 name since 2020
1 director
Documentsfilings and deeds
01-07-202630 days before the deadline
2025micro format
Gross margin from €5,365 to €8,491Profit of €1,045, after a lossDividend €800Debts from €19,144 to €16,258Cash from €6,395 to €9,831

Key points

from the 2025 annual accounts

Equity

€24,849 ▲ 1.0%
24,6032024+1,045Profit-800Dividend24,8492025

Lise Delagrange paid out €800 in dividends. That is 77% of the 2025 profit.

Filings

6 annual accounts since 2020
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 6 to 42 days before the end of the period.

Position in the sector

€1,045

Lower net result than 90% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,053 companies had the same profile as Lise Delagrange has now. Each dot stands for 13 companies, two years later.

93.9%
were still trading
3.8%
stopped another way
2.2%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,053 companies, not a prediction for Lise Delagrange. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 07-10-2020
  • 100 sharesdeed of 13-10-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0755943368
Registered office moved from Molenbeek-Saint-Jean to Dilbeek The registered office moved from Joseph Baecklaan 12, 1080 Sint-Jans-Molenbeek to Henri Moeremanslaan 36, 1700 Dilbeek · Board meeting of 30-08-2023 · Gazette deed
Incorporation Founded by · 100 shares · appointed as director · published on 13-10-2020 · Gazette deed
First establishment At the time the registered office was still in Sint-Jans-Molenbeek, Joseph Baecklaan 12.
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Lise Delagrange Dilbeek €41,106 €8,491 60.4% -
Jiibbii Sint-Genesius-Rode €34,771 €7,801 63.6% -
De Beuckelaer-Dournez Feline Stabroek €36,756 €8,656 72.4% -
PIVO7 Beringen €42,998 €10,120 86.6% -
HVDB KINE Ham-sur-Heure-Nalinnes €45,066 €8,420 80.8% -
Physioworks Heist-op-den-Berg €35,768 €8,321 30.9% -
VOXXIE Bruges €41,281 €11,375 83.8% -

These companies have the same main activity as Lise Delagrange: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €34,800 and €45,100, founded between 2018 and 2022.

Official details

Source: KBO
Status
Active since 09-10-2020Normal situation
Activity
PhysiotherapyNACE 86951and 1 other
Establishment unit
2.308.510.0271700 Dilbeek, registered on 09-10-2020
Financial year end
31 December
Peppol
Reachable since 05-10-2025
Company details

Annual accounts 2025

≈ €50,000estimated
€41,106▼ 6.0%
Filing
Filed on 01-07-2026, 30 days before the end of the filing period
Financials

Insights on Lise Delagrange

Lise Delagrange files the micro format. That format states no turnover. The gross margin fell from €21,696 in 2020 to €8,491 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Lise Delagrange

What is the company number of Lise Delagrange?
The company number of Lise Delagrange is 0755.943.368. The VAT number is the same number with BE in front: BE 0755.943.368.
Where is Lise Delagrange based?
The registered office is at H. Moeremanslaan 36, 1700 Dilbeek.Company details
What does Lise Delagrange do?
According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of Lise Delagrange?
Lise Delagrange is a private limited company (BV).
When was Lise Delagrange founded?
Lise Delagrange was founded on 09-10-2020.
Is Lise Delagrange still active?
Yes, Lise Delagrange is an active enterprise in the KBO register.
What is the turnover of Lise Delagrange?
The turnover in financial year 2025 is about €50,000. This figure is estimated from the gross margin of €8,491 and 44 comparable companies (NACE 869). It probably lies between €34,000 and €97,000. It is a rough estimate.Financials
Is Lise Delagrange profitable?
In financial year 2025, Lise Delagrange made a profit of €1,045.
Where can I find the annual accounts of Lise Delagrange?
Lise Delagrange filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Lise Delagrange due?
Lise Delagrange must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.